Monoclonal antibody routinely used to identify avirulent strains of newcastle disease virus binds to an epitope at the carboxy terminus of the hemagglutinin-neuraminidase protein and recognizes individual mesogenic and velogenic strains

Journal of Clinical Microbiology

Volumn 43, Issue 8, 2005, Pages 4229-4233

  Alamares, Judith G ^a   Li, Jianrong ^a,b   Iorio, Ronald M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HN PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AVS I; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CHICKEN; MOLECULAR RECOGNITION; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; VIROGENESIS; VIRUS IDENTIFICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANTIBODIES, MONOCLONAL; BINDING SITES, ANTIBODY; EPITOPES; HEMAGGLUTINATION INHIBITION TESTS; HN PROTEIN; NEUTRALIZATION TESTS; NEWCASTLE DISEASE VIRUS; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP; VIRULENCE;

AVES; GALLUS GALLUS; NEWCASTLE DISEASE VIRUS;

EID: 23744482980     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.8.4229-4233.2005     Document Type: Article

References (20)

1. Alexander, D. J. 1997. Newcastle disease and other avian Paramyxoviridae infections, p. 541-569. In B. W. Calnek (ed.), Diseases of poultry, 10th ed. Iowa State University Press, Ames.
2. Gelb, J., Jr., D. J. King, W. A. Wisner, and P. A. Ruggeri. 1996. Attenuation of lentogenic Newcastle disease virus strain B-1 by cold adaptation. Avian Dis. 40:605-612.
3. Glickman, R. L., R. J. Syddall, R. M. Iorio, J. P. Sheehan, and M. A. Bratt. 1988. Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus. J. Virol. 62:354-356.
4. Huang, Z., A. Panda, S. Elankumaran, D. Govindarajan, D. D. Rockemann, and S. K. Samal. 2004. The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence. J. Virol. 78:4176-4184.
5. Iorio, R. M., J. B. Borgman, R. L. Glickman, and M. A. Bratt. 1986. Genetic variation within a neutralizing domain on the haemagglutinin- neuraminidase glycoprotein of Newcastle disease virus. J. Gen. Virol. 67:1393-1403.
6. Iorio, R. M., and M. A. Bratt. 1983. Monoclonal antibodies to Newcastle disease virus: delineation of four epitopes on the HN glycoprotein. J. Virol. 48:440-450.
7. Iorio, R. M., and M. A. Bratt. 1984. Monoclonal antibodies as functional probes of the HN glycoprotein of Newcastle disease virus: antigenic separation of the hemagglutinating and neuraminidase sites. J. Immunol. 133:2215-2219.
8. Iorio, R. M., and M. A. Bratt. 1985. Selection of unique antigenic variants of Newcastle disease virus with neutralizing monoclonal antibodies and anti-immunoglobulin. Proc. Natl. Acad. Sci. USA 82:7106-7110.
9. Iorio, R. M., G. M. Field, J. M. Sauvron, A. M. Mirza, R. Deng, P. J. Mahon, and J. Langedijk. 2001. Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein: receptor recognition is dependent on neuraminidase activity. J. Virol. 75:1918-1927.
10. Iorio, R. M., R. L. Glickman, A. M. Riel, J. P. Sheehan, and M. A. Bratt. 1989. Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment. Virus Res. 13:245-261.
11. Iorio, R. M., R. L. Glickman, and J. P. Sheehan. 1992. Inhibition of fusion by neutralizing monoclonal antibodies to the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. J. Gen. Virol. 73:1167-1176.
12. Iorio, R. M., K. A. Lawton, P. M. Nicholson, and M. A. Bratt. 1984. Monoclonal antibodies identify a strain-specific epitope on the HN glycoprotein of Newcastle disease virus strain Australia-Victoria. Virus Res. 1:513-525.
13. Iorio, R. M., R. J. Syddall, J. P. Sheehan, M. A. Bratt, R. L. Glickman, and A. M. Riel. 1991. Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition. J. Virol. 65:4999-5006.
14. Nagai, Y., H. D. Klenk, and R. Rott. 1976. Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72:494-508.
15. Panda, A., Z. Huang, S. Elankumaran, D. D. Rockemann, and S. K. Samal. 2004. Role of fusion protein cleavage site in the virulence of Newcastle disease virus. Microb. Pathog. 36:1-10.
16. Peeters, B. P., O. S. de Leeuw, G. Koch, and A. L. Gielkens. 1999. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J. Virol. 73:5001-5009.
17. Sakaguchi, T., T. Toyoda, B. Gotoh, N. M. Inocencio, K. Kuma, T. Miyata, and Y. Nagai. 1989. Newcastle disease virus evolution. I. Multiple lineages defined by sequence variability of the hemagglutinin-neuraminidase gene. Virology 169:260-272.
18. Scheid, A., and P. W. Choppin. 1974. Identification of the biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology S7:475-490.
19. Srinivasappa, G. B., D. B. Snyder, W. W. Marquardt, and D. J. King. 1986. Isolation of a monoclonal antibody with specificity for commonly employed vaccine strains of Newcastle disease virus. Avian Dis. 30:562-567.
20. Toyoda, T., T. Sakaguchi, H. Hirota, B. Gotoh, K. Kuma, T. Miyata, and Y. Nagai. 1989. Newcastle disease virus evolution. II. Lack of gene recombination in generating virulent and avirulent strains. Virology 169:273-282.